- House reconciliation bill creates new subsidies for small business to help employees buy individually owned health insurance.
- How AEI would reform MA plans.
- Does exercise really help cancer survival?
- For diabetes, lifestyle changes are twice as effective as Metformin.
- Should everyone have a glucose monitor?
Category: Cost of Healthcare
New Commissioner Faces Uphill Battle to Reform FDA
The Wall Street Journal reports that the new U.S. Food and Drug Administration (FDA) commissioner Marty Makary faces numerous obstacles in his plans to remake the federal agency. Dr. Makary faces a reduction in staff, plummeting staff morale, and internal criticism that he is compromising scientific standards.
Thursday Links
- “The number of those providing genuine Marcus Welby MD style primary care … continues to fall. And it’s not too hard to figure out why. The average primary doctor makes a whole lot less than their specialty counterparts.”
- Senate Finance version of the Big, Beautiful Bill: good, bad and ugly.
- Do medical licensing laws violate the right to free speech?
- Paragon Health study: There are 6.4 million ineligible enrollees with (Obamacare) exchange coverage. Note: fraud is easy if the premium is zero.
- FDA to fast track drug approval if the manufacturer is in line with Trump’s health goals (like producing drugs in this country).
Wednesday Links
- AAF: Contra Biden Admin., monopoly is not a problem in the US economy.
- Richard McKensie: Trump’s “beautiful bill” will raise federal spending in 2035 to at least 24 percent of GDP from 23.1 percent this year (and 20.6 percent in 2019, before COVID)
- Use and misuse of Ivermectin.
- Covid Redux: “The Centers for Disease Control and Prevention advisory committee decided to inoculate essential workers ahead of seniors, even though its own modeling suggested this would increase deaths by up to 7 percent.”
- More evidence that taxes on capital affect investment.